John M. Storring

1.5k total citations
21 papers, 608 citations indexed

About

John M. Storring is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, John M. Storring has authored 21 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in John M. Storring's work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers) and Hemoglobinopathies and Related Disorders (4 papers). John M. Storring is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers) and Hemoglobinopathies and Related Disorders (4 papers). John M. Storring collaborates with scholars based in Canada, United States and New Zealand. John M. Storring's co-authors include Paul R. Albert, Xiao‐Ming Ou, Neena Kushwaha, Andre C. Schuh, Karen Yee, Joseph Brandwein, Juanhong Meng, Hamed Jafar‐Nejad, Sylvie Lemonde and Mark D. Minden and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

John M. Storring

20 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Storring Canada 12 217 179 169 132 128 21 608
Zulma Dueñas Colombia 11 156 0.7× 48 0.3× 19 0.1× 66 0.5× 49 0.4× 28 494
Antonella Mulas Italy 7 128 0.6× 36 0.2× 26 0.2× 70 0.5× 88 0.7× 10 481
Edith Arnold Mexico 14 190 0.9× 65 0.4× 19 0.1× 45 0.3× 33 0.3× 32 590
Yvet Kroeze Netherlands 9 93 0.4× 29 0.2× 104 0.6× 58 0.4× 36 0.3× 13 394
Hidetoshi Taniguchi Japan 13 237 1.1× 44 0.2× 56 0.3× 40 0.3× 70 0.5× 19 550
Maggie Lai United Kingdom 9 138 0.6× 78 0.4× 7 0.0× 42 0.3× 42 0.3× 12 512
Jean‐Pierre Max France 14 84 0.4× 38 0.2× 20 0.1× 131 1.0× 50 0.4× 28 653
Marek Kaciński Poland 12 88 0.4× 30 0.2× 14 0.1× 86 0.7× 80 0.6× 71 400
Krystyna Mitosek‐Szewczyk Poland 13 138 0.6× 17 0.1× 26 0.2× 55 0.4× 14 0.1× 35 630
Kate K. O’Toole United States 11 169 0.8× 73 0.4× 13 0.1× 183 1.4× 43 0.3× 14 473

Countries citing papers authored by John M. Storring

Since Specialization
Citations

This map shows the geographic impact of John M. Storring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Storring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Storring more than expected).

Fields of papers citing papers by John M. Storring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Storring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Storring. The network helps show where John M. Storring may publish in the future.

Co-authorship network of co-authors of John M. Storring

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Storring. A scholar is included among the top collaborators of John M. Storring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Storring. John M. Storring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckstein, Rena, Karen Yee, Michelle Geddes, et al.. (2023). The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leukemia & lymphoma. 64(3). 651–661. 3 indexed citations
2.
3.
Leitch, Heather A., Rena Buckstein, Nancy Zhu, et al.. (2018). Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS. Leukemia Research. 74. 21–41. 24 indexed citations
4.
Vinh, Donald C., et al.. (2018). GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia. Journal of Pediatric Hematology/Oncology. 40(4). e225–e228. 4 indexed citations
5.
6.
DeAngelo, Daniel J., Kristen E. Stevenson, Donna Neuberg, et al.. (2015). A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial. Blood. 126(23). 80–80. 37 indexed citations
7.
8.
Seftel, Matthew D., Michael J. Barnett, Stephen Couban, et al.. (2014). A Canadian Consensus on the Management of Newly Diagnosed and Relapsed Acute Promyelocytic Leukemia in Adults. Current Oncology. 21(5). 234–250. 19 indexed citations
9.
Wells, Richard A., Brian Leber, Nancy Zhu, & John M. Storring. (2014). Optimizing Outcomes with Azacitidine: Recommendations from Canadian Centres of Excellence. Current Oncology. 21(1). 44–50. 12 indexed citations
10.
Paulson, Kristjan, Pascal Lambert, Julie Bergeron, et al.. (2014). Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study. British Journal of Haematology. 166(5). 660–666. 38 indexed citations
11.
Brandwein, Joseph, Michelle Geddes, Jeannine Kassis, et al.. (2013). Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.. PubMed. 3(2). 141–64. 12 indexed citations
12.
Leitch, Heather A., Rena Buckstein, April Shamy, & John M. Storring. (2012). The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline. Critical Reviews in Oncology/Hematology. 85(2). 162–192. 10 indexed citations
13.
Michel, René P., et al.. (2012). Long-Term Remission after Autologous Stem-Cell Transplantation for Relapsed Histiocytic Sarcoma. Current Oncology. 19(4). 289–291. 11 indexed citations
14.
Storring, John M., Mark D. Minden, Vikas Gupta, et al.. (2009). Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen. British Journal of Haematology. 146(1). 76–85. 111 indexed citations
15.
Storring, John M., Joseph Brandwein, Vikas Gupta, et al.. (2006). Treatment of Adult Acute Lymphoblastic Leukemia (ALL) with a Modified DFCI Pediatric Regimen - The Princess Margaret Experience.. Blood. 108(11). 1875–1875. 7 indexed citations
16.
Abdouh, Mohamed, John M. Storring, Mustapha Riad, et al.. (2001). Transcriptional Mechanisms for Induction of 5-HT1AReceptor mRNA and Protein in Activated B and T Lymphocytes. Journal of Biological Chemistry. 276(6). 4382–4388. 59 indexed citations
17.
Ou, Xiao‐Ming, John M. Storring, Neena Kushwaha, & Paul R. Albert. (2001). Heterodimerization of Mineralocorticoid and Glucocorticoid Receptors at a Novel Negative Response Element of the 5-HT1A Receptor Gene. Journal of Biological Chemistry. 276(17). 14299–14307. 142 indexed citations
18.
Ou, Xiao‐Ming, Hamed Jafar‐Nejad, John M. Storring, et al.. (2000). Novel Dual Repressor Elements for Neuronal Cell-specific Transcription of the Rat 5-HT1A Receptor Gene. Journal of Biological Chemistry. 275(11). 8161–8168. 57 indexed citations
19.
Storring, John M., et al.. (1999). TATA‐Driven Transcriptional Initiation and Regulation of the Rat Serotonin 5‐HT1A Receptor Gene. Journal of Neurochemistry. 72(6). 2238–2247. 34 indexed citations
20.
Albert, Paul R., Stephen J. Morris, Mohammad H. Ghahremani, John M. Storring, & Paola Lembo. (1998). A Putative α‐helical Gβγ‐coupling Domain in the Second Intracellular Loop of the 5‐HT1A Receptora. Annals of the New York Academy of Sciences. 861(1). 146–161. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zulma Dueñas Breakdown of academic impact, for papers by Antonella Mulas Breakdown of academic impact, for papers by Edith Arnold Breakdown of academic impact, for papers by Yvet Kroeze Breakdown of academic impact, for papers by Hidetoshi Taniguchi Breakdown of academic impact, for papers by Maggie Lai Breakdown of academic impact, for papers by Jean‐Pierre Max Breakdown of academic impact, for papers by Marek Kaciński Breakdown of academic impact, for papers by Krystyna Mitosek‐Szewczyk Breakdown of academic impact, for papers by Kate K. O’Toole
Rankless by CCL
2026